1st Quarter - Report

BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

Firm
Client
Income
—
Expenses
$1,920,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

20 issue areas, each in the filer's own words, with who lobbied on it and where.

Accounting ACC

Accelerating of NOLs in Lieu of Other Tax Benefits (Refundable Tax Credit/Grant Proposals) H.R. 1. and S. Amdt. 570: American Recovery & Reinvestment Act of 2009

LobbyistCovered position, as disclosed
BRENT ALAN DELMONTE —
ALAN EISENBERG —
SHELLY MUI-LIPNIK —
PAUL POTEET —
MATTHEW SCHUMAKER New Executive Director, New Democrat Coalition
TOOSHAR SWAIN Legislative Correspondent, Senator Rick Santorum

Contacted: Office of Science & Technology Policy (OSTP); Environmental Protection Agency (EPA); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Commerce, Dept of (DOC); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); SENATE; White House Office; Patent & Trademark Office (PTO); U.S. Agency for International Development (USAID); Food & Drug Administration (FDA); Agriculture, Dept of (USDA); Natl Institutes of Health (NIH)

Bills named: H.R. 1 (111th)

Medicare/Medicaid MMM

Medicaid Rebates H.Con. Res. 85/S.Con. Res 13: Setting Forth the Congressional Budget for the United States Government for FY 2010

LobbyistCovered position, as disclosed
MELISSA BOWIE Chief Health Counsel, Senate HELP Subcommittee
TRICIA BROOKS —
BRENT ALAN DELMONTE —
JEANNE HAGGERTY —
LAUREN PARKER NEFF Legislative Assistant, Rep. Deborah Pryce
MATTHEW SCHUMAKER New Executive Director, New Democrat Coalition
LAUREL TODD —

Contacted: Commerce, Dept of (DOC); Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); White House Office; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); Agriculture, Dept of (USDA); Office of Science & Technology Policy (OSTP); SENATE; State, Dept of (DOS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; U.S. Agency for International Development (USAID)

Bills named: S.Con.Res. 13 (111th), H.Con.Res. 85 (111th)

Economics/Economic Development ECN

Economic Incentives for Biotech Industry H.Con. Res. 85/S.Con. Res 13: Setting Forth the Congressional Budget for the United States Government for FY 2010

LobbyistCovered position, as disclosed
PATRICK BRAERTON CARROLL Legislative Assistant, Rep. Ray LaHood
BRENT ALAN DELMONTE —
ALAN EISENBERG —
PAUL POTEET —
MATTHEW SCHUMAKER New Executive Director, New Democrat Coalition

Contacted: Commerce, Dept of (DOC); White House Office; Agriculture, Dept of (USDA); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; SENATE; Natl Institutes of Health (NIH); Office of Science & Technology Policy (OSTP); Food & Drug Administration (FDA); U.S. Agency for International Development (USAID); Office of Management & Budget (OMB); Patent & Trademark Office (PTO); State, Dept of (DOS)

Bills named: S.Con.Res. 13 (111th), H.Con.Res. 85 (111th)

Agriculture AGR

Livestock Cloning/Product Labeling FDA Risk Assessment on Cloning USDA Economic Research Service Report on Impact of Cloning on US Agriculture and Food Production USDA National Organic Program Livestock Cloning/Product Labeling Cont... H.R. 1105: Omnibus Appropriations for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 USDA APHIS Animal Care USDA National Institute of Food & Agriculture, Agriculture Food Research Initiative, Research Funding Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Foreign Agriculture Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement China Biotechnology Bilateral Discussions Mexico Biotechnology Bilateral Discussions Taiwan Biotechnology Bilateral Discussions EU Biotechnology Bilateral Discussions Canada Biotechnology Bilateral Discussions Japan Biotechnology Bilateral Discussions Argentina Biotechnology Bilateral Discussions Brazil Biotechnology Bilateral Discussions Colombia Biotechnology Bilateral Discussions Negotiations of Trans Pacific Partnership APEC Agricultural Biotechnology Discussions Korean Biosafety Law Discussions with EU on Animal Cloning Adventitious Presence (Low Level Presence) U.S. Government Policy for Codex Guidelines on Adventitious Presence European Union Low Level Presence Policy Philippines Low Level Presence Policy World Trade Organization on EU Biotech Approvals Review of EU Biotechnology Negotiations Genetically Engineered (GE) Animals Coordination Between Federal Agencies FDA Final Guidance on Regulation of GE Animals FDA CBER Blood Products Advisory Committee Meeting FDA Approval of First Product from GE Animal USDA APHIS Biotechnology Research Service Request for Information USDA APHIS Animal Care USDA APHIS Veterinary Service USDA National Institute of Food & Agriculture, Agriculture Food Research Institute, Research Funding Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings USDA/APHIS Agricultural Biotechnology Regulations USDA Rulemaking on 7CFR 340 U.S. Policy on Sustainable Agriculture Standard Funding for the USDA H.R. 1105: Omnibus Appropriations for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Appropriations Act for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Appropriations Act for FY 2010 Biomass Crop Assistance Program (BCAP) BCAP Rulemaking and Environmental Impact Statement 2007 Farm Bill Implementation

LobbyistCovered position, as disclosed
SHARON BOMER LAURITSEN —
PATRICK BRAERTON CARROLL Legislative Assistant, Rep. Ray LaHood
BRENT ALAN DELMONTE —
BARBARA GLENN —
SARAH LUKIE —
BILL A OLSON Legislative Assistant, Rep. John Shimkus

Contacted: Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Office of Management & Budget (OMB); U.S. Agency for International Development (USAID); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Office of Science & Technology Policy (OSTP); Agriculture, Dept of (USDA); Food & Drug Administration (FDA); State, Dept of (DOS); Commerce, Dept of (DOC); White House Office; SENATE; Patent & Trademark Office (PTO); Environmental Protection Agency (EPA)

Bills named: H.R. 1105 (111th)

Small Business SMB

Small Business Innovation and Research (SBIR) Program Reauthorization SBA Grant Proposal for High-Growth Companies Accelerating of NOLs in Lieu of Other Tax Benefits (Refundable Tax Credits/Grant Proposals) H.R. 1. and S. Amdt. 570: American Recovery & Reinvestment Act of 2009

LobbyistCovered position, as disclosed
BRENT ALAN DELMONTE —
ALAN EISENBERG —
ELIZABETH CARTIER ESHAM —
SHELLY MUI-LIPNIK —
PAUL POTEET —
MATTHEW SCHUMAKER New Executive Director, New Democrat Coalition
TOOSHAR SWAIN Legislative Correspondent, Senator Rick Santorum

Contacted: U.S. Trade Representative (USTR); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); White House Office; Food & Drug Administration (FDA); Office of Science & Technology Policy (OSTP); Agriculture, Dept of (USDA); Office of Management & Budget (OMB); U.S. Agency for International Development (USAID); Patent & Trademark Office (PTO); Natl Institutes of Health (NIH); State, Dept of (DOS)

Bills named: H.R. 1 (111th)

Pharmacy PHA

Comparative Effectiveness Program Initiatives H.R. 1. and S.Amdt. 570: American Recovery and Reinvestment Act of 2009 Drug Safety Implementation of Food & Drug Administration Act of 2007 E-Pedigree and Anti-counterfeiting Safeguarding America's Pharmaceuticals Act of 2009 (House Discussion Draft) FDA Globalization Act of 2009 (House Discussion Draft) S.525: Pharmaceutical Market Access and Drug Safety The Drug and Device Accountability Act of 2009 (Senate Discussion Draft) Drug Importation S.525: Pharmaceutical Market Access and Drug Safety H.R. 1105: Omnibus Appropriations for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Funding for the Food and Drug Administration H.R. 1105: Omnibus Appropriations for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Medicaid Rebates H.Con. Res. 85/S.Con. Res 13: Setting Forth the Congressional Budget for the United States Government for FY 2010

LobbyistCovered position, as disclosed
MELISSA BOWIE Chief Health Counsel, Senate HELP, Subcommi
EDWARD BUCKLEY —
PATRICK BRAERTON CARROLL Legislative Assistant, Rep. Ray LaHood
BRENT ALAN DELMONTE —
SANDRA DENNIS —
TOM DILENGE —
ANDREW EMMETT —
JEANNE HAGGERTY —
KATHERINE MCCARTHY —
LAUREN PARKER NEFF Legislative Assistant, Rep. Deborah Pryce
SARA RADCLIFFE —
MATTHEW SCHUMAKER New Executive Director, New Democrat Coalition
JOHN MACK TAYLOR —
LAUREL TODD —

Contacted: Office of Science & Technology Policy (OSTP); White House Office; Commerce, Dept of (DOC); Patent & Trademark Office (PTO); SENATE; State, Dept of (DOS); Health & Human Services, Dept of (HHS); U.S. Agency for International Development (USAID); U.S. Trade Representative (USTR); Office of Management & Budget (OMB); Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA)

Bills named: S. 525 (111th), H.Con.Res. 85 (111th), S.Con.Res. 13 (111th), H.R. 1105 (111th), H.R. 1 (111th)

Medical/Disease Research/Clinical Labs MED

Funding for the Food and Drug Administration H.R. 1105: Omnibus Appropriations for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Funding for Bioterrorism and Emergency Preparedness H.R. 1. and S.Amdt. 570: American Recovery and Reinvestment Act of 2009 H.R. 1105: Omnibus Appropriations for FY 2009 Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2009 Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2010 Funding for National Institutes of Health H.R. 1. and S.Amdt. 570: American Recovery and Reinvestment Act of 2009 H.R. 1105: Omnibus Appropriations for FY 2009 Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2009 Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2010 Funding for Biomedical Advanced Research Development Authority (BARDA) H.R. 1. and S.Amdt. 570: American Recovery and Reinvestment Act of 2009 H.R. 1105: Omnibus Appropriations for FY 2009 Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2009 Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2010 Funding for Pandemic Influenza Preparedness H.R. 1. and S.Amdt. 570: American Recovery and Reinvestment Act of 2009 H.R. 1105: Omnibus Appropriations for FY 2009 Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2009 Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2010 In Vitro Diagnostics Regulatory Oversight Comparative Effectiveness Program Initiatives H.R. 1. and S. Amdt. 570: American Recovery and Reinvestment Act of 2009 Stem Cell Research Executive Order Drug Safety Implementation of Food & Drug Administration Act of 2007 E-Pedigree and Anti-counterfeiting Safeguarding America's Pharmaceuticals Act of 2009 (House Discussion Draft) FDA Globalization Act of 2009 (House Discussion Draft) S.525: Pharmaceutical Market Access and Drug Safety The Drug and Device Accountability Act of 2009 (Senate Discussion Draft)

LobbyistCovered position, as disclosed
MELISSA BOWIE Chief Health Counsel, Senate HELP Subcommittee
EDWARD BUCKLEY —
PATRICK BRAERTON CARROLL Legislative Assistant, Rep. Ray LaHood
SANDRA DENNIS —
TOM DILENGE —
ANDREW EMMETT —
ELIZABETH CARTIER ESHAM —
JEANNE HAGGERTY —
KATHERINE MCCARTHY —
LAUREN PARKER NEFF Legislative Assistant, Rep. Deborah Pryce
DARYL PRITCHARD —
SARA RADCLIFFE —
MATTHEW SCHUMAKER New Executive Director, New Democrat Coalition
JOHN MACK TAYLOR —
LAUREL TODD —

Contacted: U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); Office of Science & Technology Policy (OSTP); Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); Patent & Trademark Office (PTO); SENATE; Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Food & Drug Administration (FDA); White House Office; U.S. Agency for International Development (USAID); Office of Management & Budget (OMB); Agriculture, Dept of (USDA)

Bills named: H.R. 1105 (111th), H.R. 1 (111th), S. 525 (111th)

Copyright/Patent/Trademark CPT

Patent Reform H.R. 1260: The Patent Reform Act of 2009 S. 515. The Patent Reform Act of 2009 S. 610: The Patent Reform Act of 2009 PTO Reform CBD TRIPS Amendment Patent Disclosure Requirements

LobbyistCovered position, as disclosed
MELISSA BOWIE Chief Health Counsel, Senate HELP Subcommittee
TRICIA BROOKS —
EDWARD BUCKLEY —
BRENT ALAN DELMONTE —
TOM DILENGE —
LILA FEISEE —
JEANNE HAGGERTY —
PAUL POTEET —
HANSJORG SAUER —
MATTHEW SCHUMAKER Executive Director, New Democrat Coalition
JOHN MACK TAYLOR —

Contacted: Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Office of Science & Technology Policy (OSTP); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; U.S. Agency for International Development (USAID); Agriculture, Dept of (USDA); U.S. Trade Representative (USTR); Commerce, Dept of (DOC); White House Office; Office of Management & Budget (OMB); SENATE; State, Dept of (DOS)

Bills named: H.R. 1260 (111th), S. 515 (111th), S. 610 (111th)

Health Issues HCR

Health Care Reform H.Con. Res. 85/S.Con. Res 13: Setting Forth the Congressional Budget for the United States Goverment for FY 2010 Drug Safety Implementation of Food & Drug Administration Act of 2007 E-Pedigree and Anti-counterfeiting Safeguarding America's Pharmaceuticals Act of 2009 (House Discussion Draft) FDA Globalization Act of 2009 (House Discussion Draft) S.525: Pharmaceutical Market Access and Drug Safety The Drug and Device Accountability Act of 2009 (Senate Discussion Draft) Drug Importation S.525: Pharmaceutical Market Access and Drug Safety H.R. 1105: Omnibus Appropriations for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Funding for the Food and Drug Administration H.R. 1105: Omnibus Appropriations for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Stem Cell Research Executive Order Medicaid Rebates H.Con. Res. 85/S.Con. Res 13: Setting Forth the Congressional Budget for the United States Government for FY 2010 Follow-on Biologics H.R. 1427: Promoting Innovation and Access to Life-Saving Medicines Act H.R. 1548: Pathway for Biosimilars Act of 2009 S. 726: Promoting Innovation and Access to Life-Saving Medicine Act H.Con. Res. 85/S.Con. Res 13: Setting Forth the Congressional Budget for the United States Government for FY 2010 Funding for Biomedical Advanced Research & Development Authority (BARDA) H.R. 1105: Omnibus Appropriations for FY 2009 Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2009 Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2010 H.R. 1. and S.Amdt. 570: American Recovery and Reinvestment Act of 2009 Vaccine Financing National Vaccine Advisory Committee Draft Recommendations In Vitro Diagnostics Regulatory Oversight Comparative Effectiveness Program Initiatives H.R. 1. and S.Amdt. 570: American Recovery and Reinvestment Act of 2009 Funding for National Institutes of Health H.R. 1. and S.Amdt. 570: American Recovery and Reinvestment Act of 2009 H.R. 1105: Omnibus Appropriations for FY 2009 Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2009 Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2010 Funding for Bioterrorism and Emergency Preparedness H.R. 1. and S.Amdt. 570: American Recovery and Reinvestment Act of 2009 H.R. 1105: Omnibus Appropriations for FY 2009 Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2009 Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2010 Funding for Pandemic Influenza Preparedness H.R. 1. and S.Amdt. 570: American Recovery and Reinvestment Act of 2009 H.R. 1105: Omnibus Appropriations for FY 2009 Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2009 Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2010 Reporting of Physician Payments S. 301: Physician Payments Sunshine Act of 2009

LobbyistCovered position, as disclosed
MELISSA BOWIE Chief Health Counsel, Senate HELP Subcommit
TRICIA BROOKS —
EDWARD BUCKLEY —
PATRICK BRAERTON CARROLL Legislative Assistant, Rep. Ray LaHood
BRENT ALAN DELMONTE —
SANDRA DENNIS —
TOM DILENGE —
ANDREW EMMETT —
ELIZABETH CARTIER ESHAM —
JEANNE HAGGERTY —
KELLY LAI —
KATHERINE MCCARTHY —
LAUREN PARKER NEFF Legislative Assistant, Rep. Deborah Pryce
DARYL PRITCHARD —
SARA RADCLIFFE —
HANSJORG SAUER —
MATTHEW SCHUMAKER New Executive Director, New Democrat Coalition
JOHN MACK TAYLOR —
LAUREL TODD —

Contacted: U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Office of Management & Budget (OMB); State, Dept of (DOS); U.S. Agency for International Development (USAID); Agriculture, Dept of (USDA); Commerce, Dept of (DOC); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); White House Office; SENATE; Patent & Trademark Office (PTO); Office of Science & Technology Policy (OSTP); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1 (111th), H.R. 1427 (111th), S. 726 (111th), H.Con.Res. 85 (111th), S. 301 (111th), H.R. 1548 (111th), S. 525 (111th), H.R. 1105 (111th), S.Con.Res. 13 (111th)

Food Industry (safety, labeling, etc.) FOO

Adventitious Presence (Low Level Presence) U.S. Government Policy for Codex Guidelines on Adventitious Presence European Union Low Level Presence Policy Philippines Low Level Presence Policy Genetically Engineered (GE) Animals Coordination Between Federal Agencies FDA Final Guidance on Regulation of GE Animals FDA CBER Blood Products Advisory Committee Meeting FDA Approval of First Product from GE Animal USDA APHIS Biotechnology Research Service Request for Information USDA APHIS Animal Care USDA APHIS Veterinary Service USDA National Institute of Food & Agriculture, Agriculture Food Research Institute, Research Funding Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Livestock Cloning/Product Labeling FDA Risk Assessment on Cloning USDA Economic Research Service Report on Impact of Cloning on US Agriculture and Food Production USDA National Organic Program H.R. 1105: Omnibus Appropriations for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 USDA APHIS Animal Care USDA National Institute of Food & Agriculture, Agriculture Food Research Initiative, Research Funding Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Food Safety Funding H.R. 1105: Omnibus Appropriations for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 1010

LobbyistCovered position, as disclosed
SHARON BOMER LAURITSEN —
PATRICK BRAERTON CARROLL Legislative Assistant, Rep. Ray LaHood
BRENT ALAN DELMONTE —
BARBARA GLENN —
SARAH LUKIE —
BILL A OLSON Legislative Assistant, Rep. John Shimkus

Contacted: Health & Human Services, Dept of (HHS); White House Office; Agriculture, Dept of (USDA); U.S. Trade Representative (USTR); Office of Science & Technology Policy (OSTP); Commerce, Dept of (DOC); Office of Management & Budget (OMB); State, Dept of (DOS); Natl Institutes of Health (NIH); Patent & Trademark Office (PTO); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); U.S. Agency for International Development (USAID); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1105 (111th)

Trade (domestic/foreign) TRD

Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agriculture Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement China Biotechnology Bilateral Discussions Mexico Biotechnology Bilateral Discussions Taiwan Biotechnology Bilateral Discussions EU Biotechnology Bilateral Discussions Canada Biotechnology Bilateral Discussions Japan Biotechnology Bilateral Discussions Argentina Biotechnology Bilateral Discussions Brazil Biotechnology Bilateral Discussions Colombia Biotechnology Bilateral Discussions Negotiations of Trans Pacific Partnership APEC Agricultural Biotechnology Discussions Korean Biosafety Law Discussions with EU on Animal Cloning Adventitious Presence (Low Level Presence) U.S. Government Policy for Codex Guidelines on Adventitious Presence European Union Low Level Presence Policy Philippines Low Level Presence Policy World Trade Organization on EU Biotech Approvals Review of EU Biotechnology Negotiations CBD TRIPS Amendment Patent Disclosure Requirements Drug Importation S.525: Pharmaceutical Market Access and Drug Safety H.R. 1105: Omnibus Appropriations for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009

LobbyistCovered position, as disclosed
SHARON BOMER LAURITSEN —
PATRICK BRAERTON CARROLL Legislative Assistant, Rep. Ray LaHood
BRENT ALAN DELMONTE —
ANDREW EMMETT —
LILA FEISEE —
SARAH LUKIE —
BILL A OLSON Legislative Asst., Rep. John Shimkus
PAUL POTEET —
SARA RADCLIFFE —

Contacted: Health & Human Services, Dept of (HHS); White House Office; Agriculture, Dept of (USDA); Environmental Protection Agency (EPA); U.S. Agency for International Development (USAID); Patent & Trademark Office (PTO); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Office of Management & Budget (OMB); U.S. Trade Representative (USTR); State, Dept of (DOS); Natl Institutes of Health (NIH); SENATE; Office of Science & Technology Policy (OSTP)

Bills named: H.R. 1105 (111th), S. 525 (111th)

Taxation/Internal Revenue Code TAX

Accelerating of NOLs in Lieu of Other Tax Benefits (Refundable Tax Credits/Grant Proposals) H.R. 1. and S. Amdt. 570: American Recovery & Reinvestment Act of 2009 Investment Tax Credit for Therapeutic Development

LobbyistCovered position, as disclosed
BRENT ALAN DELMONTE —
ALAN EISENBERG —
SHELLY MUI-LIPNIK —
PAUL POTEET —
MATTHEW SCHUMAKER New Executive Director, New Democrat Coalition
TOOSHAR SWAIN Legislative Correspondent, Senator Rick Santorum

Contacted: White House Office; Office of Management & Budget (OMB); Agriculture, Dept of (USDA); SENATE; Health & Human Services, Dept of (HHS); Office of Science & Technology Policy (OSTP); Commerce, Dept of (DOC); State, Dept of (DOS); Environmental Protection Agency (EPA); Patent & Trademark Office (PTO); Food & Drug Administration (FDA); U.S. Agency for International Development (USAID); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Natl Institutes of Health (NIH)

Bills named: H.R. 1 (111th)

Budget/Appropriations BUD

H.R. 1105: Omnibus Appropriations for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 Funding for the Food and Drug Administration (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine) Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 Cont... Funding for the USDA: Biotechnology Regulatory Service (APHIS), Animal Care & Veterinary Services (APHIS), Trade Activities (Office of the Secretary & Food Safety Inspection Service), Agriculture Research Service, Biofuels (Rural Development)) Drug Importation Livestock Cloning/Product Labeling Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Funding for National Institutes of Health Funding for Bioterrorism and Emergency Preparedness Funding for Pandemic Influenza Preparedness Funding for Biomedical Advanced Research and Development Authority (BARDA) Drug Importation Energy and Water Development and Related Agencies Appropriations Act for FY 2009 Biofuels Funding at the Department of Energy Commerce, Justice, Science, and Related Agencies Appropriations Act for FY 2009 Funding for Technology Innovation Program at National Institute of Standards and Technology Department of State, Foreign Operations and Related Programs Appropriations Act for FY 2009 Funding for Biotechnology Research and Development Programs at the Agency for International Development H.R. 1. and S.Amdt. 570: American Recovery and Reinvestment Act of 2009 Comparative Effectiveness Research Funding for National Institutes of Health Funding for Bioterrorism and Emergency Preparedness Funding for Pandemic Influenza Preparedness Funding for Biofuels Funding for Biomedical Advanced Research and Development Authority (BARDA) Funding for Technology Innovation Program at National Institute of Standards and Technology Funding for the USDA: Biotechnology Regulatory Service (APHIS), Animal Care & Veterinary Services (APHIS), Trade Activities (Office of the Secretary & Food Safety Inspection Service), Agriculture Research Service, Biofuels (Rural Development)) H.Con. Res. 85/S.Con. Res 13: Setting Forth the Congressional Budget for the United States Government for FY 2010 Medicaid Rebates Healthcare Reform Follow-on Biologics Economic Incentives for Biotech Industry Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Funding for the Food and Drug Administration (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine) . Funding for the USDA: Biotechnology Regulatory Service (APHIS), Animal Care & Veterinary Services (APHIS), Trade Activities (Office of the Secretary & Food Safety Inspection Service), Agriculture Research Service, Biofuels (Rural Development)) Genetically Engineered (GE) Animals Livestock Cloning/Product Labeling Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2010 Funding for National Institutes of Health Funding for Bioterrorism and Emergency Preparedness Funding for Pandemic Influenza Preparedness Funding for Biomedical Advanced Research and Development Authority (BARDA) Energy and Water Development and Related Agencies Appropriations Act for FY 2010 Funding for Biofuels at the Department of Energy Commerce, Justice, Science, and Related Agencies Appropriations Act for FY 2010 Funding for Technology Innovation Program at National Institute of Standards and Technology Department of State, Foreign Operations and Related Programs Appropriations Act for FY 2010 Funding for Biotechnology Research and Development Programs at the Agency for International Development

LobbyistCovered position, as disclosed
SHARON BOMER LAURITSEN —
MELISSA BOWIE Chief Health Counsel, Senate HELP, Subcommittee
TRICIA BROOKS —
EDWARD BUCKLEY —
PATRICK BRAERTON CARROLL Legislative Assistant, Rep. Ray LaHood
BRENT ALAN DELMONTE —
SANDRA DENNIS —
TOM DILENGE —
ANDREW EMMETT —
BARBARA GLENN —
JEANNE HAGGERTY —
LAUREN PARKER NEFF Legislative Asst., Rep. Deborah Pryce
BILL A OLSON Legislative Assistant, Rep. John Shimkus
PAUL POTEET —
DARYL PRITCHARD —
SARA RADCLIFFE —
MATTHEW SCHUMAKER New Executive Director, New Democrat Coalition
JOHN MACK TAYLOR —
LAUREL TODD —

Contacted: Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); U.S. Agency for International Development (USAID); Food & Drug Administration (FDA); Commerce, Dept of (DOC); U.S. Trade Representative (USTR); Agriculture, Dept of (USDA); Patent & Trademark Office (PTO); State, Dept of (DOS); White House Office; Natl Institutes of Health (NIH); Office of Science & Technology Policy (OSTP); SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1105 (111th), H.Con.Res. 85 (111th), H.R. 1 (111th), S.Con.Res. 13 (111th)

Consumer Issues/Safety/Products CSP

Adventitious Presence (Low Level Presence) U.S. Government Policy for Codex Guidelines on Adventitious Presence European Union Low Level Presence Policy Philippines Low Level Presence Policy Genetically Engineered (GE) Animals Coordination Between Federal Agencies FDA Final Guidance on Regulation of GE Animals FDA CBER Blood Products Advisory Committee Meeting FDA Approval of First Product from GE Animal USDA APHIS Biotechnology Research Service Request for Information USDA APHIS Animal Care USDA APHIS Veterinary Service USDA National Institute of Food & Agriculture, Agriculture Food Research Institute, Research Funding Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Drug Safety Implementation of Food & Drug Administration Act of 2007 E-Pedigree and Anti-counterfeiting Safeguarding America's Pharmaceuticals Act of 2009 (House Discussion Draft) FDA Globalization Act of 2009 (House Discussion Draft) S.525: Pharmaceutical Market Access and Drug Safety The Drug and Device Accountability Act of 2009 (Senate Discussion Draft) Drug Importation S.525: Pharmaceutical Market Access and Drug Safety H.R. 1105: Omnibus Appropriations for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2009 Funding for the Food and Drug Administration H.R. 1105: Omnibus Appropriations for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Reporting of Physician Payments S:310: Physician Payments Sunshine Act of 2009 Livestock Cloning/Product Labeling FDA Risk Assessment on Cloning USDA Economic Research Service Report on Impact of Cloning on US Agriculture and Food Production USDA National Organic Program H.R. 1105: Omnibus Appropriations for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 USDA APHIS Animal Care USDA National Institute of Food & Agriculture, Agriculture Food Research Initiative, Research Funding Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010

LobbyistCovered position, as disclosed
SHARON BOMER LAURITSEN —
MELISSA BOWIE Chief Health Counsel, Senate HELP Subcommittee
PATRICK BRAERTON CARROLL Legislative Assistant, Rep. Ray LaHood
BRENT ALAN DELMONTE —
SANDRA DENNIS —
TOM DILENGE —
ANDREW EMMETT —
BARBARA GLENN —
JEANNE HAGGERTY —
SARAH LUKIE —
KATHERINE MCCARTHY —
BILL A OLSON Legislative Assistant, Rep. John Shimkus
SARA RADCLIFFE —
MATTHEW SCHUMAKER New Executive Director, New Democrat Coalition
JOHN MACK TAYLOR —

Contacted: U.S. Agency for International Development (USAID); Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); State, Dept of (DOS); Natl Institutes of Health (NIH); White House Office; Food & Drug Administration (FDA); Office of Management & Budget (OMB); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE; Patent & Trademark Office (PTO); Office of Science & Technology Policy (OSTP); Agriculture, Dept of (USDA)

Bills named: S. 525 (111th), H.R. 1105 (111th)

Energy/Nuclear ENG

Renewable Fuels Standard EPA Rulemaking on Life Cycle Greenhouse Gas Emissions Requirements Implementation of Energy Independence and Security Act of 2007 Biofuels Investment in Commercialization Investment in Distribution and Delivery Infrastructure Increase in Federal R&D Investment H.R. 1. and S.Amdt. 570: American Recovery & Reinvestment Act of 2009 H.R. 1105: Omnibus Appropriations for FY 2009 Energy and Water Development and Related Agencies Appropriations Act for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 Energy and Water Development and Related Agencies Appropriations Act for FY 2010 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Bio-based Products Investment in Distribution and Delivery Infrastructure Investment in Commercialization H.R. 1. and S.Amdt. 570: American Recovery and Reinvestment Act of 2009 Biotech Incentives in Climate Change Legislation American Clean Energy and Security Act of 2009 (Discussion Draft) Offsets and Credits for Biotech Solutions

LobbyistCovered position, as disclosed
MATT CARR —
PATRICK BRAERTON CARROLL Legislative Assistant, Rep. Ray LaHood
BRENT ALAN DELMONTE —
AMY EHLERS —
BRENT ERICKSON —
BILL A OLSON —
PAUL POTEET —

Contacted: Patent & Trademark Office (PTO); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Commerce, Dept of (DOC); White House Office; U.S. Agency for International Development (USAID); Health & Human Services, Dept of (HHS); SENATE; U.S. Trade Representative (USTR); Agriculture, Dept of (USDA); Natl Institutes of Health (NIH); State, Dept of (DOS); Office of Science & Technology Policy (OSTP); Environmental Protection Agency (EPA)

Bills named: H.R. 1 (111th), H.R. 1105 (111th)

Animals ANI

Livestock Cloning/Product Labeling FDA Risk Assessment on Cloning USDA Economic Research Service Report on Impact of Cloning on US Agriculture and Food Production USDA National Organic Program Livestock Cloning/Product Labeling Cont... H.R. 1105: Omnibus Appropriations for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 USDA APHIS Animal Care USDA National Institute of Food & Agriculture, Agriculture Food Research Initiative, Research Funding Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Genetically Engineered (GE) Animals Coordination Between Federal Agencies FDA Final Guidance on Regulation of GE Animals FDA CBER Blood Products Advisory Committee Meeting FDA Approval of First Product from GE Animal USDA APHIS Biotechnology Research Service Request for Information USDA APHIS Animal Care USDA APHIS Veterinary Service USDA National Institute of Food & Agriculture, Agriculture Food Research Institute, Research Funding Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010

LobbyistCovered position, as disclosed
SHARON BOMER LAURITSEN —
PATRICK BRAERTON CARROLL Legislative Assistant, Rep. Ray LaHood
BRENT ALAN DELMONTE —
BARBARA GLENN —
BILL A OLSON Legislative Assistant, Rep. John Shimkus

Contacted: Commerce, Dept of (DOC); Agriculture, Dept of (USDA); U.S. Trade Representative (USTR); Environmental Protection Agency (EPA); Patent & Trademark Office (PTO); Office of Management & Budget (OMB); SENATE; State, Dept of (DOS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; U.S. Agency for International Development (USAID); Natl Institutes of Health (NIH); Office of Science & Technology Policy (OSTP); Health & Human Services, Dept of (HHS); White House Office

Bills named: H.R. 1105 (111th)

Science/Technology SCI

Stem Cell Research Executive Order Small Business Innovation and Research (SBIR) Program Reauthorization SBA Grant Proposal for High-Growth Companies Technology Innovation Program (TIP) H.R. 1105: Omnibus Appropriations for FY 2009 Commerce, Justice, Science, and Related Agencies Appropriations Act for FY 2009 Commerce, Justice, Science, and Related Agencies Appropriations Act for FY 2010

LobbyistCovered position, as disclosed
PATRICK BRAERTON CARROLL Legislative Assistant, Rep. Ray LaHood
BRENT ALAN DELMONTE —
ALAN EISENBERG —
ELIZABETH CARTIER ESHAM —
PAUL POTEET —
MATTHEW SCHUMAKER New Executive Director, New Democrat Coalition

Contacted: Commerce, Dept of (DOC); Office of Science & Technology Policy (OSTP); Environmental Protection Agency (EPA); Natl Institutes of Health (NIH); Agriculture, Dept of (USDA); White House Office; State, Dept of (DOS); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Patent & Trademark Office (PTO); SENATE; Office of Management & Budget (OMB); U.S. Agency for International Development (USAID); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1105 (111th)

Fuel/Gas/Oil FUE

Renewable Fuels Standard EPA Rulemaking on Life Cycle Greenhouse Gas Emissions Requirements Implementation of Energy Independence and Security Act of 2007 Biofuels Investment in Commercialization Investment in Distribution and Delivery Infrastructure H.R. 1. and S.Amdt. 570: American Recovery & Reinvestment Act of 2009 Increase in Federal R&D Investment H.R. 1105: Omnibus Appropriations for FY 2009 Energy and Water Development and Related Agencies Appropriations Act for FY 2009 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2009 Energy and Water Development and Related Agencies Appropriations Act for FY 2010 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Bio-based Products Investment in Distribution and Delivery Infrastructure Investment in Commercialization H.R. 1. and S.Amdt. 570: American Recovery and Reinvestment Act of 2009 Biotech Incentives in Climate Change Legislation American Clean Energy and Security Act of 2009 (Discussion Draft) Offsets and Credits for Biotech Solutions

LobbyistCovered position, as disclosed
MATT CARR —
PATRICK BRAERTON CARROLL Legislative Assistant, Rep. Ray LaHood
BRENT ALAN DELMONTE —
AMY EHLERS —
BRENT ERICKSON —
BILL A OLSON Legislative Assistant, Rep. John Shimkus

Contacted: U.S. Agency for International Development (USAID); U.S. Trade Representative (USTR); Environmental Protection Agency (EPA); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Patent & Trademark Office (PTO); SENATE; Food & Drug Administration (FDA); Office of Science & Technology Policy (OSTP); Commerce, Dept of (DOC); State, Dept of (DOS); Agriculture, Dept of (USDA); White House Office

Bills named: H.R. 1 (111th), H.R. 1105 (111th)

Homeland Security HOM

Funding for Pandemic Influenza Preparedness H.R. 1. and S.Amdt. 570: American Recovery and Reinvestment Act of 2009 Funding for Pandemic Influenza Preparedness Cont... H.R. 1105: Omnibus Appropriations for FY 2009 Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2009 Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2010 Funding for Biomedical Advanced Research Development Authority (BARDA) H.R. 1. and S.Amdt. 570: American Recovery and Reinvestment Act of 2009 H.R. 1105: Omnibus Appropriations for FY 2009 Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2009 Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2010 Funding for Bioterrorism and Emergency Preparedness H.R. 1. and S.Amdt. 570: American Recovery and Reinvestment Act of 2009 H.R. 1105: Omnibus Appropriations for FY 2009 Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2009 Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2010

LobbyistCovered position, as disclosed
PATRICK BRAERTON CARROLL Legislative Assistant, Rep. Ray LaHood
BRENT ALAN DELMONTE —
SARA RADCLIFFE —
JOHN MACK TAYLOR —

Contacted: Agriculture, Dept of (USDA); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; SENATE; Environmental Protection Agency (EPA); Natl Institutes of Health (NIH); State, Dept of (DOS); U.S. Agency for International Development (USAID); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); White House Office; Food & Drug Administration (FDA); Office of Science & Technology Policy (OSTP); Patent & Trademark Office (PTO)

Bills named: H.R. 1 (111th), H.R. 1105 (111th)

Clean Air and Water (quality) CAW

Biotech Incentives in Climate Change Legislation American Clean Energy and Security Act of 2009 (Discussion Draft) Offsets and Credits for Biotech Solutions

LobbyistCovered position, as disclosed
MATT CARR —
AMY EHLERS —
BRENT ERICKSON —
BILL A OLSON Legislative Assistant, Rep. John Shimkus

Contacted: Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); U.S. Agency for International Development (USAID); Office of Science & Technology Policy (OSTP); State, Dept of (DOS); SENATE; Natl Institutes of Health (NIH); Agriculture, Dept of (USDA); U.S. Trade Representative (USTR); White House Office; Office of Management & Budget (OMB)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.